BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $187,000 | -51.9% | 15,168 | -46.9% | 0.00% | -100.0% |
| Q4 2016 | $389,000 | -37.9% | 28,579 | -9.2% | 0.00% | 0.0% |
| Q3 2016 | $626,000 | +41.3% | 31,478 | -7.9% | 0.00% | 0.0% |
| Q2 2016 | $443,000 | +37.6% | 34,178 | -0.9% | 0.00% | 0.0% |
| Q1 2016 | $322,000 | -55.5% | 34,478 | -3.4% | 0.00% | 0.0% |
| Q4 2015 | $723,000 | +3.1% | 35,678 | -26.1% | 0.00% | 0.0% |
| Q3 2015 | $701,000 | -2.8% | 48,278 | +42.4% | 0.00% | 0.0% |
| Q2 2015 | $721,000 | +111.4% | 33,899 | +130.6% | 0.00% | 0.0% |
| Q1 2015 | $341,000 | +40.9% | 14,700 | +40.0% | 0.00% | – |
| Q4 2014 | $242,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 918,000 | $11,328,000 | 4.35% |
| EMORY UNIVERSITY | 164,607 | $2,031,000 | 1.92% |
| Monashee Investment Management LLC | 160,000 | $1,974,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 210,260 | $2,595,000 | 0.65% |
| CORRADO ADVISORS, LLC | 83,622 | $1,032,000 | 0.59% |
| Foresite Capital Management II, LLC | 105,000 | $1,296,000 | 0.56% |
| Baker Brothers Advisors | 5,032,313 | $62,099,000 | 0.51% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $2,468,000 | 0.48% |
| Clearline Capital LP | 55,200 | $681,000 | 0.32% |
| LMR Partners LLP | 270,594 | $3,339,000 | 0.32% |